Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2Blood GlucoseDiabetes MellitusHypoglycemic AgentsHemoglobin A, GlycosylatedInsulinGlucoseDiabetes Mellitus, ExperimentalDiabetic NephropathiesDiabetic NeuropathiesDiabetes ComplicationsBlood Glucose Self-MonitoringCase-Control StudiesRisk FactorsGlucose Tolerance TestObesityIslets of LangerhansHypoglycemiaHyperglycemiaMice, Inbred NODDiabetes, GestationalGlucose IntoleranceGlutamate DecarboxylaseStreptozocinPrediabetic StateC-PeptideInsulin-Secreting CellsDiabetic AngiopathiesDiabetic RetinopathyIslets of Langerhans TransplantationTime FactorsPregnancy in DiabeticsRats, Inbred BBFastingPancreas TransplantationGenetic Predisposition to DiseasePancreasAlbuminuriaMetforminHLA-DQ AntigensInsulin Infusion SystemsBiological MarkersPostprandial PeriodAutoantibodiesBlood PressureBody Mass IndexGlucose Transporter Type 1Glucose OxidaseEchovirus 9Insulin ResistanceFollow-Up StudiesGlucose Transporter Type 4Diagnostic EquipmentSulfonylurea CompoundsPrevalenceGlucagonTreatment OutcomeGenotypeBody WeightSelf CareCross-Sectional StudiesProspective StudiesCohort StudiesHypertensionRetrospective StudiesCardiovascular DiseasesLipidsAutoimmune DiseasesPolymorphism, Single NucleotideMonosaccharide Transport ProteinsAutoimmunityInfusions, SubcutaneousDeoxyglucoseTriglyceridesGlucose Transporter Type 2Diabetic KetoacidosisCells, CulturedRats, Sprague-DawleyLiverNuclear FamilyDiabetic DietAutoantigensPatient Education as TopicDisease Models, AnimalGlycosuriaAllelesGluconeogenesisDisease ProgressionDiabetes InsipidusGlucagon-Like Peptide 1GlipizideInsulin, Long-ActingGliclazideGlucose 1-DehydrogenaseGlycogenIncidenceReference ValuesMice, Inbred C57BLGlucokinase